期刊
NEUROREPORT
卷 29, 期 5, 页码 426-431出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0000000000000987
关键词
apoptosis; blood-brain barrier; cerebral ischemic injury; glucose metabolism; 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy--d-pyranoside; pharmacokinetics; salidroside analog
资金
- National Key Basic Research Program of China (973 program) [2014CB542203]
- National Natural Science Foundation of China [81401094, 81371389]
- Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD)
2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxyb-d-pyranoside (code-named SalA-4g), an analog of salidroside, has potent neuroprotective effects. In this study, the pharmacological properties of SalA-4g were evaluated in primary cortical neurons exposed to oxygen and glucose deprivation and in a rat model of transient middle cerebral artery occlusion. The results of pharmacokinetic and brain distribution studies indicated that SalA-4g could pass through the blood-brain barrier with a relatively short elimination time. 3-[4,5-Dimethyl-2-thiazolyl]-2,5-diphenyl tetrazolium bromide assay, terminal deoxynucleotidyl transferase dUTP nick-end labeling, and Annexin V staining collectively showed that SalA-4g inhibited neuronal viability loss and apoptosis in a concentration-dependent manner in an oxygen and glucose deprivation model. Fluorine-18-fluorodeoxyglucose PET/CT imaging indicated that SalA-4g improved metabolic recovery in the ischemic hemisphere in a rat middle cerebral artery occlusion model. Our findings provide further evidence of the potential therapeutic applications of SalA-4g for the treatment of cerebral ischemic injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据